NOUSCOM POSTER PRESENTATION AT EACR Annual Congress Of The European Association For Cancer Research 2023, Turin June 11-14
TITLE: Adenovirus encoded anti-CTLA-4 is a potent genetic adjuvant of Adenovirus based neoantigen vaccine for more robust and effective anti-tumor response.
Abstract#P-0393: Nocchi et al
Recent Posts